Carnegie Mellon University »

Carmell Therapeutics Corp - US shares owned by Carnegie Mellon University

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Carnegie Mellon University from 13F filings

Historical chart of Carnegie Mellon University investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Carnegie Mellon University consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Carnegie Mellon University

Quarter filed Position value Share count Share price at filing
2023-12-31 $393k 103k 3.81
2023-09-30 $371k 103k 3.60

More positions owned by Carnegie Mellon University

Duolingo Cl A Com (DUOL)
Carmell Therapeutics Corp - US (CTCX)
Vera Therapeutics Cl A (VERA)
Neubase Therapeutics Com New (NBSE)
Predictive Oncology (POAI)
Innsuites Hospitality Trust Sh Ben Int (IHT)

View all positions for Carnegie Mellon University

Top funds holding Carmell Therapeutics Corp - US

Vanguard Group
Carnegie Mellon University
Citadel Advisors
Hubbell Strickland Wealth Management
UBS Group
Wells Fargo & Company
Royal Bank of Canada
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Carmell Therapeutics Corp - US